2019-06-11 15:48:20

Results 1 - 8 of 8
Public Title Project Description Modified
Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to less than 4 Years . . . SP0967 is a Phase 3, multicenter, double-blind, randomized, PBO-controlled, parallel-group study to . . . 28 Jun 2019 03:46:30
Long-term Extension Study to Investigate Lacosamide as an Add-on Therapy in Children with Partial On . . . EP0034 is a Phase 3, multicenter, open-label, extension study to obtain long-term safety and efficac . . . 20 Jun 2019 05:14:14
Informal Economy Segmentation Study: Towards UHC in the Philippines - Reaching and Retaining Members . . . The impending approval of the Universal Health Coverage Law necessitates operationalization of the d . . . 11 Jun 2019 03:49:59
26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral . . . This protocol describes a 6-month, open label extension study (A1281201) of the A1281198 study. This . . . 11 Jul 2019 10:51:16
Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Subjects With Advanced HC . . . This is a multicenter, randomized, open-label, controlled Phase 3 trial of cabozantinib in combinati . . . 25 Jun 2019 05:58:10
A 12-week phase 3, randomized, double-blind, placebo controlled study to evaluate the efficacy and . . . This study uses a single-cohort, 2-treatment arms, randomized (1:1 (70 mg:placebo)), double-blind st . . . 20 Jun 2019 05:03:36
A Phase III Double-blind Randomised Study Assessing the Efficacy and Safety of Capivasertib + Paclit . . . This is a Phase III, double-blind, randomised study assessing the efficacy of capivasertib + paclita . . . 20 Jun 2019 05:18:33
Long Term Follow-up of Immunogenicity of Healthy Filipino Adults and Children who participated in Ph . . . Phase I study showed the Vi-DT test vaccine was safe, well tolerated, and elicited good immune respo . . . 25 Jun 2019 05:54:06

Copyright © One Window Project 2018. All rights reserved.